Uncommon but Not Unknown: Efficacy of EGFR-TKIs for Uncommon Mutations
Prof. James Chih-Hsin Yang discussed about the distribution of uncommon EGFR mutations in NSCLC patients and the available evidence and insights regarding the clinical activity of EGFR-TKIs and other newer agents against these mutations.
Speaker: Prof. James Chih-Hsin Yang
Document ID: PC-SG-100730
Speaker
Prof. James Chih-Hsin Yang
Distinguished Professor,
Director, Graduate Institute of Oncology
National Taiwan University,
Taiwan
Director, Department of Oncology
National Taiwan University Hospital,
Taiwan
Uncommon but Not Unknown: Efficacy of EGFR-TKIs for Uncommon Mutations - Q&A
Speaker: Prof. James Chih-Hsin Yang
